Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1210 | 1054 | 1229 | 1265 | 1353 | 2162 |
Fund Return | 20.98% | 5.44% | 22.94% | 8.15% | 6.23% | 8.02% |
Place in category | 1043 | 1161 | 1180 | 704 | 1190 | 422 |
% in Category | 61 | 66 | 68 | 49 | 94 | 70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Canadian Div Fund Series F | 22.69B | 21.66 | 10.83 | 8.46 | ||
RBC Canadian Div Fund Series D | 22.69B | 21.36 | 10.52 | 8.15 | ||
RBC Sel Gr Port Sr A | 17.92B | 17.70 | 5.16 | 6.86 | ||
RBC Sel Gr Port Sr F | 17.92B | 18.79 | 6.23 | 7.95 | ||
RBC US Div Sr D | 7.98B | 32.49 | 13.49 | 12.90 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators F USD | 16.18B | 55.54 | 14.87 | - | ||
Capital Group Global Equity Fd F | 14.04B | 27.39 | 5.28 | 11.77 | ||
Capital Group Global Equity Fd A | 14.04B | 26.11 | 4.12 | 10.53 | ||
Capital Group Global Equity Fd D | 14.04B | 27.03 | 4.93 | 11.29 | ||
Mackenzie Global Dividend Fund A | 7.25B | 23.12 | 9.15 | 10.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
KDDI Corp. | JP3496400007 | 3.06 | 4,931.0 | -0.44% | |
Colgate-Palmolive | US1941621039 | 2.99 | 92.39 | +0.52% | |
Costco | US22160K1051 | 2.96 | 958.82 | +0.94% | |
Kimberly-Clark | US4943681035 | 2.92 | 132.18 | +0.56% | |
P&G | US7427181091 | 2.88 | 168.94 | +0.49% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review